The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews

Chan, Raymond Javan; Crichton, Megan; Crawford‐Williams, Fiona; Agbejule, Oluwaseyifunmi Andi; Yu, Kexin; Hart, Nicholas; Alves, Fábio de Abreu; Ashbury, Fredrick D.; Eng, Lawson; Fitch, Margaret I.; Jain, Hasmukh; Jefford, Michael; Klemanski, Dori; Koczwara, Bogda; Loh, Kiley Wei-Jen; Prasad, Maya; Rugo, Hope S.; Soto‐Pérez‐de‐Celis, Enrique; Hurk, Corina van den; Chan, Alexandre

doi:10.1016/j.annonc.2021.09.001

Cited by 88 publications

(78 citation statements)

References 54 publications

(412 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The deficit of rheumatologists has led to diagnostic delays in many diseases [ 4 ] and a decline in treatment effectiveness [ 5 ]. In recent decades, information and communication technologies have entered health care [ 6 , 7 , 8 , 9 , 10 , 11 ] with telemedicine as one promising field of application.…”

Section: Introductionmentioning

confidence: 99%

Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study

Muehlensiepen

Knitza

Marquardt³

et al. 2021

IJERPH

View full text Add to dashboard Cite

Despite all its promises, telemedicine is still not widely implemented in the care of rheumatic and musculoskeletal diseases (RMDs). The aim of this study is to investigate opportunities, barriers, acceptance, and preferences concerning telemedicine among RMD patients and professional stakeholders. From November 2017 to December 2019, a participatory, mixed-methods study was conducted, consisting of (1) expert interviews (n = 27) with RMD patients and professional stakeholders, (2) a national paper-based patient survey (n = 766), and (3) focus groups (n = 2) with patient representatives and rheumatologists. The qualitative findings indicate that patients equate personal contact with physical face-to-face contact, which could be reduced by implementing telemedicine, thus negatively influencing the patient–doctor relationship. Correspondingly “no personal contact with the doctor” is the main reason (64%) why 38% of the surveyed patients refuse to try telemedicine. Professional stakeholders expect telemedicine to contribute to the effective allocation of scarce resources in rheumatology care. The main barriers reported by stakeholders were the scarcity of time resources in RMD care, the absence of physical examinations, and organizational challenges associated with the implementation of telemedicine in RMD care. While the exact integration of telemedicine into routine care has yet to be found, the consequences on the patient-physician relationship must be permanently considered.

show abstract

Section: Introductionmentioning

confidence: 99%

Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study

Muehlensiepen

Knitza

Marquardt³

et al. 2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…We have shown that more than a quarter of CCS seeking care in 2020 had forgone health care over this period. Although this rate of forgoing care may have been balanced by a greater use of teleconsultations, which have been found in the literature to improve the management of physical and psychosocial effects in cancer survivors [ 29 ], we observed that 80% of CCS who had forgone care had not used teleconsultations. Indeed, an increased perceived risk combined with possible difficulties in accessing care may have led to avoiding seeking treatment, mainly for fear of contracting the disease, resulting in a delay in the management of late effects in CCS during the COVID-19 pandemic.…”

Section: Discussionmentioning

confidence: 73%

Risk perceptions and health care use in the era of the COVID-19 pandemic in adults treated for childhood cancer

Janah

Vathaire

Bougas

et al. 2022

Support Care Cancer

View full text Add to dashboard Cite

Purpose During the COVID-19 pandemic, childhood cancer survivors (CCS) may have felt more at risk of having severe consequences of COVID-19 and therefore may have been more likely to defer their health care use. We aimed to assess the risk perceptions of CCS related to COVID-19 (perceived infection risk, perceived risk of experiencing a severe illness in the event of infection), and their forgoing of health care during the year 2020. Methods In December 2020, we interviewed through an online self-report questionnaire 580 5-year CCS participating in the French Childhood Cancer Survivor Study (FCCSS) cohort. Combining clinical and patient-reported outcomes, we studied predictors of perceived risks related to COVID-19 and forgoing health care. Results Overall, 60% of respondents stated that COVID-19 could have severe consequences for their health if infected. Survivors with a cardiovascular disease and those who felt more at risk of being infected were more likely to think that COVID-19 could have severe health consequences for them. Moreover, 30% of respondents seeking care declared they had forgone at least one medical appointment in 2020. Forgoing medical appointments was more common among CCS who reported a deterioration in their financial situation in 2020 and those who felt more at risk of being infected. Conclusions This study shows that a considerable proportion of survivors had forgone medical appointments because of the pandemic; forgoing care was more frequent among the most socioeconomically disadvantaged survivors. Implications for cancer survivors. This study presents data hitherto absent in the literature and suggests the need to develop telehealth to ensure appropriate long-term follow-up of CCS.

show abstract

“…A sudden rush, however, to digital care might diminish the quality of clinical care, i.e., in situations in which there is an inability to perform an adequate physical exam, a need to address sensitive topics, limited access to technological devices, low digital literacy, or a perceived ethical or security concern [ 24 , 33 – 35 ]. In a large colorectal population in the Netherlands, 12.2% ( n = 379) of the patients indicated that their in-person visit was changed into a teleconsultation during the first month of the pandemic.…”

Section: Discussionmentioning

confidence: 99%

The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer

Molen

Bargon

Batenburg

et al. 2021

Breast Cancer Res Treat

View full text Add to dashboard Cite

Purpose To evaluate perceived access to health care and preferences for health care provision among patients (being) treated for breast cancer during the COVID-19 pandemic. Methods Longitudinal study within the prospective, multicenter UMBRELLA cohort of patients (being) treated for breast cancer. All cohort participants enrolled in UMBRELLA between October 2013 and November 2020 were sent a COVID-19-specific survey during the first and second wave of the COVID-19 pandemic, i.e., April 2020 and November 2020, respectively. Results In total, 1106 (69.3%) and 822 (50.9%) cohort participants completed the survey in the first and second wave, respectively. The proportion of patients experiencing that their treatment or follow-up care was affected due to COVID-19 decreased from 28.4% ( n = 198) in April 2020 to 14.8% ( n = 103) in November 2020. Throughout the pandemic, one or more hospital consultations were postponed in 10.0% ( n = 82) of all patients and changed into a teleconsultation in 23.1% ( n = 190). The proportion of patients who experienced a higher threshold to contact their general practitioner due to COVID-19 decreased from 29.9% ( n = 204) in the first wave to 20.8% ( n = 145) in the second wave. In-person consultations remained most preferred in 35.2% ( n = 289) of all patients. Nearly half of all patients (48.3%, n = 396) indicated that telehealth would be a useful alternative for in-person consultations in future. Conclusion Perceived access to health care has improved substantially throughout the pandemic. Digital care is well received by patients (being) treated for breast cancer. Supplementary Information The online version contains supplementary material available at 10.1007/s10549-021-06458-3.

show abstract

The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews

Cited by 88 publications

References 54 publications

Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study

Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study

Risk perceptions and health care use in the era of the COVID-19 pandemic in adults treated for childhood cancer

The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer

Contact Info

Product

Resources

About